Early Treatment of High-Risk Hospitalized Coronavirus Disease 2019 (COVID-19) Patients With a Combination of Interferon Beta-1b and Remdesivir: A Phase 2 Open-label Randomized Controlled Trial
采用干扰素β-1b和瑞德西韦联合治疗高危住院新型冠状病毒肺炎(COVID-19)患者:一项II期开放标签随机对照试验
期刊:Clinical Infectious Diseases
影响因子:7.3
doi:10.1093/cid/ciac523
Tam, Anthony Raymond; Zhang, Ricky Ruiqi; Lung, Kwok-Cheung; Liu, Raymond; Leung, Ka-Yi; Liu, Danlei; Fan, Yujing; Lu, Lu; Lam, Athene Hoi-Ying; Chung, Tom Wai-Hin; Yip, Cyril Chik-Yan; Lo, Jenny; Wu, Alan Ka-Lun; Lee, Rodney; Sin, Simon; Ng, Pauline Yeung; Chan, Wai-Ming; Shum, Hoi-Ping; Yan, Wing-Wa; Chan, Jasper Fuk-Woo; Cheng, Vincent Chi-Chung; Lau, Chak-Sing; To, Kelvin Kai-Wang; Chan, Kwok-Hung; Yuen, Kwok-Yung; Hung, Ivan Fan-Ngai